世界の麻酔（オピオイド）薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Narcotic (Opioid) Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4023 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、麻酔（オピオイド）薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コデイン、フェンタニル、ヒドロコドン、ヒドロモルフォン、メペリジン、メサドン、その他）、用途別市場規模（鎮痛用、麻酔用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・麻酔（オピオイド）薬の市場動向 ・企業の競争状況、市場シェア ・麻酔（オピオイド）薬の種類別市場規模（コデイン、フェンタニル、ヒドロコドン、ヒドロモルフォン、メペリジン、メサドン、その他） ・麻酔（オピオイド）薬の用途別市場規模（鎮痛用、麻酔用） ・麻酔（オピオイド）薬の北米市場規模2016-2027（アメリカ、カナダ） ・麻酔（オピオイド）薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・麻酔（オピオイド）薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・麻酔（オピオイド）薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・麻酔（オピオイド）薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Teva、Purdue Pharma、Mallinckrodt、Amneal Pharma、Collegium、Johnson & Johnson、Merck、Mylan、Hikma Pharmaceuticals、Sun Pharma、Endo Pharmaceuticals、Allergan） ・結論

Narcotics, also called opioids, are a necessary and important part of medical care. They include strong prescription pain relievers, such as oxycodone, hydrocodone, fentanyl, and tramadol. The illegal drug heroin is also an opioid. Some opioids are made from the opium plant, and others are synthetic (man-made).

Market Analysis and Insights: Global Narcotic (Opioid) Drugs Market
The global Narcotic (Opioid) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Narcotic (Opioid) Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Narcotic (Opioid) Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Narcotic (Opioid) Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Narcotic (Opioid) Drugs market.

Global Narcotic (Opioid) Drugs Scope and Market Size
Narcotic (Opioid) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Narcotic (Opioid) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Codeine
Fentanyl
Hydrocodone
Hydromorphone
Meperidine
Methadone
Others

Segment by Application
Pain Relief Application
Anesthesia Application

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
Johnson & Johnson
Merck
Mylan
Hikma Pharmaceuticals
Sun Pharma

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Codeine
1.2.3 Fentanyl
1.2.4 Hydrocodone
1.2.5 Hydromorphone
1.2.6 Meperidine
1.2.7 Methadone
1.2.8 Others
1.3 Market by Application
1.3.1 Global Narcotic (Opioid) Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pain Relief Application
1.3.3 Anesthesia Application
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Narcotic (Opioid) Drugs Market Perspective (2016-2027)
2.2 Narcotic (Opioid) Drugs Growth Trends by Regions
2.2.1 Narcotic (Opioid) Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Narcotic (Opioid) Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Narcotic (Opioid) Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Narcotic (Opioid) Drugs Industry Dynamic
2.3.1 Narcotic (Opioid) Drugs Market Trends
2.3.2 Narcotic (Opioid) Drugs Market Drivers
2.3.3 Narcotic (Opioid) Drugs Market Challenges
2.3.4 Narcotic (Opioid) Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Narcotic (Opioid) Drugs Players by Revenue
3.1.1 Global Top Narcotic (Opioid) Drugs Players by Revenue (2016-2021)
3.1.2 Global Narcotic (Opioid) Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Narcotic (Opioid) Drugs Revenue
3.4 Global Narcotic (Opioid) Drugs Market Concentration Ratio
3.4.1 Global Narcotic (Opioid) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Narcotic (Opioid) Drugs Revenue in 2020
3.5 Narcotic (Opioid) Drugs Key Players Head office and Area Served
3.6 Key Players Narcotic (Opioid) Drugs Product Solution and Service
3.7 Date of Enter into Narcotic (Opioid) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Narcotic (Opioid) Drugs Breakdown Data by Type
4.1 Global Narcotic (Opioid) Drugs Historic Market Size by Type (2016-2021)
4.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2022-2027)

5 Narcotic (Opioid) Drugs Breakdown Data by Application
5.1 Global Narcotic (Opioid) Drugs Historic Market Size by Application (2016-2021)
5.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Narcotic (Opioid) Drugs Market Size (2016-2027)
6.2 North America Narcotic (Opioid) Drugs Market Size by Type
6.2.1 North America Narcotic (Opioid) Drugs Market Size by Type (2016-2021)
6.2.2 North America Narcotic (Opioid) Drugs Market Size by Type (2022-2027)
6.2.3 North America Narcotic (Opioid) Drugs Market Size by Type (2016-2027)
6.3 North America Narcotic (Opioid) Drugs Market Size by Application
6.3.1 North America Narcotic (Opioid) Drugs Market Size by Application (2016-2021)
6.3.2 North America Narcotic (Opioid) Drugs Market Size by Application (2022-2027)
6.3.3 North America Narcotic (Opioid) Drugs Market Size by Application (2016-2027)
6.4 North America Narcotic (Opioid) Drugs Market Size by Country
6.4.1 North America Narcotic (Opioid) Drugs Market Size by Country (2016-2021)
6.4.2 North America Narcotic (Opioid) Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Narcotic (Opioid) Drugs Market Size (2016-2027)
7.2 Europe Narcotic (Opioid) Drugs Market Size by Type
7.2.1 Europe Narcotic (Opioid) Drugs Market Size by Type (2016-2021)
7.2.2 Europe Narcotic (Opioid) Drugs Market Size by Type (2022-2027)
7.2.3 Europe Narcotic (Opioid) Drugs Market Size by Type (2016-2027)
7.3 Europe Narcotic (Opioid) Drugs Market Size by Application
7.3.1 Europe Narcotic (Opioid) Drugs Market Size by Application (2016-2021)
7.3.2 Europe Narcotic (Opioid) Drugs Market Size by Application (2022-2027)
7.3.3 Europe Narcotic (Opioid) Drugs Market Size by Application (2016-2027)
7.4 Europe Narcotic (Opioid) Drugs Market Size by Country
7.4.1 Europe Narcotic (Opioid) Drugs Market Size by Country (2016-2021)
7.4.2 Europe Narcotic (Opioid) Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size (2016-2027)
8.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type
8.2.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application
8.3.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region
8.4.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Narcotic (Opioid) Drugs Market Size (2016-2027)
9.2 Latin America Narcotic (Opioid) Drugs Market Size by Type
9.2.1 Latin America Narcotic (Opioid) Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Narcotic (Opioid) Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Narcotic (Opioid) Drugs Market Size by Type (2016-2027)
9.3 Latin America Narcotic (Opioid) Drugs Market Size by Application
9.3.1 Latin America Narcotic (Opioid) Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Narcotic (Opioid) Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Narcotic (Opioid) Drugs Market Size by Application (2016-2027)
9.4 Latin America Narcotic (Opioid) Drugs Market Size by Country
9.4.1 Latin America Narcotic (Opioid) Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Narcotic (Opioid) Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size (2016-2027)
10.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type
10.2.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application
10.3.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country
10.4.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Narcotic (Opioid) Drugs Introduction
11.1.4 Pfizer Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Narcotic (Opioid) Drugs Introduction
11.2.4 Teva Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
11.2.5 Teva Recent Development
11.3 Purdue Pharma
11.3.1 Purdue Pharma Company Details
11.3.2 Purdue Pharma Business Overview
11.3.3 Purdue Pharma Narcotic (Opioid) Drugs Introduction
11.3.4 Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
11.3.5 Purdue Pharma Recent Development
11.4 Mallinckrodt
11.4.1 Mallinckrodt Company Details
11.4.2 Mallinckrodt Business Overview
11.4.3 Mallinckrodt Narcotic (Opioid) Drugs Introduction
11.4.4 Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
11.4.5 Mallinckrodt Recent Development
11.5 Amneal Pharma
11.5.1 Amneal Pharma Company Details
11.5.2 Amneal Pharma Business Overview
11.5.3 Amneal Pharma Narcotic (Opioid) Drugs Introduction
11.5.4 Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
11.5.5 Amneal Pharma Recent Development
11.6 Collegium
11.6.1 Collegium Company Details
11.6.2 Collegium Business Overview
11.6.3 Collegium Narcotic (Opioid) Drugs Introduction
11.6.4 Collegium Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
11.6.5 Collegium Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Narcotic (Opioid) Drugs Introduction
11.8.4 Merck Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Narcotic (Opioid) Drugs Introduction
11.9.4 Mylan Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
11.9.5 Mylan Recent Development
11.10 Hikma Pharmaceuticals
11.10.1 Hikma Pharmaceuticals Company Details
11.10.2 Hikma Pharmaceuticals Business Overview
11.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Introduction
11.10.4 Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
11.10.5 Hikma Pharmaceuticals Recent Development
11.11 Sun Pharma
11.11.1 Sun Pharma Company Details
11.11.2 Sun Pharma Business Overview
11.11.3 Sun Pharma Narcotic (Opioid) Drugs Introduction
11.11.4 Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
11.11.5 Sun Pharma Recent Development
11.12 Endo Pharmaceuticals
11.12.1 Endo Pharmaceuticals Company Details
11.12.2 Endo Pharmaceuticals Business Overview
11.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Introduction
11.12.4 Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
11.12.5 Endo Pharmaceuticals Recent Development
11.13 Allergan
11.13.1 Allergan Company Details
11.13.2 Allergan Business Overview
11.13.3 Allergan Narcotic (Opioid) Drugs Introduction
11.13.4 Allergan Revenue in Narcotic (Opioid) Drugs Business (2016-2021)
11.13.5 Allergan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Codeine
Table 3. Key Players of Fentanyl
Table 4. Key Players of Hydrocodone
Table 5. Key Players of Hydromorphone
Table 6. Key Players of Meperidine
Table 7. Key Players of Methadone
Table 8. Key Players of Others
Table 9. Global Narcotic (Opioid) Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Narcotic (Opioid) Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Narcotic (Opioid) Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Narcotic (Opioid) Drugs Market Share by Regions (2016-2021)
Table 13. Global Narcotic (Opioid) Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Narcotic (Opioid) Drugs Market Share by Regions (2022-2027)
Table 15. Narcotic (Opioid) Drugs Market Trends
Table 16. Narcotic (Opioid) Drugs Market Drivers
Table 17. Narcotic (Opioid) Drugs Market Challenges
Table 18. Narcotic (Opioid) Drugs Market Restraints
Table 19. Global Narcotic (Opioid) Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Narcotic (Opioid) Drugs Market Share by Players (2016-2021)
Table 21. Global Top Narcotic (Opioid) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcotic (Opioid) Drugs as of 2020)
Table 22. Ranking of Global Top Narcotic (Opioid) Drugs Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Narcotic (Opioid) Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Narcotic (Opioid) Drugs Product Solution and Service
Table 26. Date of Enter into Narcotic (Opioid) Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Narcotic (Opioid) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2016-2021)
Table 30. Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Narcotic (Opioid) Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Narcotic (Opioid) Drugs Revenue Market Share by Application (2016-2021)
Table 34. Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Narcotic (Opioid) Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Narcotic (Opioid) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Narcotic (Opioid) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Narcotic (Opioid) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Narcotic (Opioid) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Narcotic (Opioid) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Narcotic (Opioid) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Narcotic (Opioid) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Narcotic (Opioid) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Narcotic (Opioid) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Narcotic (Opioid) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Narcotic (Opioid) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Narcotic (Opioid) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Narcotic (Opioid) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Narcotic (Opioid) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Narcotic (Opioid) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Narcotic (Opioid) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Narcotic (Opioid) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Narcotic (Opioid) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Narcotic (Opioid) Drugs Product
Table 69. Pfizer Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Narcotic (Opioid) Drugs Product
Table 74. Teva Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
Table 75. Teva Recent Development
Table 76. Purdue Pharma Company Details
Table 77. Purdue Pharma Business Overview
Table 78. Purdue Pharma Narcotic (Opioid) Drugs Product
Table 79. Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
Table 80. Purdue Pharma Recent Development
Table 81. Mallinckrodt Company Details
Table 82. Mallinckrodt Business Overview
Table 83. Mallinckrodt Narcotic (Opioid) Drugs Product
Table 84. Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
Table 85. Mallinckrodt Recent Development
Table 86. Amneal Pharma Company Details
Table 87. Amneal Pharma Business Overview
Table 88. Amneal Pharma Narcotic (Opioid) Drugs Product
Table 89. Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
Table 90. Amneal Pharma Recent Development
Table 91. Collegium Company Details
Table 92. Collegium Business Overview
Table 93. Collegium Narcotic (Opioid) Drugs Product
Table 94. Collegium Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
Table 95. Collegium Recent Development
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Narcotic (Opioid) Drugs Product
Table 99. Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
Table 100. Johnson & Johnson Recent Development
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
Table 104. Merck Recent Development
Table 105. Mylan Company Details
Table 106. Mylan Business Overview
Table 107. Mylan Narcotic (Opioid) Drugs Product
Table 108. Mylan Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
Table 109. Mylan Recent Development
Table 110. Hikma Pharmaceuticals Company Details
Table 111. Hikma Pharmaceuticals Business Overview
Table 112. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product
Table 113. Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
Table 114. Hikma Pharmaceuticals Recent Development
Table 115. Sun Pharma Company Details
Table 116. Sun Pharma Business Overview
Table 117. Sun Pharma Narcotic (Opioid) Drugs Product
Table 118. Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
Table 119. Sun Pharma Recent Development
Table 120. Endo Pharmaceuticals Company Details
Table 121. Endo Pharmaceuticals Business Overview
Table 122. Endo Pharmaceuticals Narcotic (Opioid) Drugs Product
Table 123. Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
Table 124. Endo Pharmaceuticals Recent Development
Table 125. Allergan Company Details
Table 126. Allergan Business Overview
Table 127. Allergan Narcotic (Opioid) Drugs Product
Table 128. Allergan Revenue in Narcotic (Opioid) Drugs Business (2016-2021) & (US$ Million)
Table 129. Allergan Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Narcotic (Opioid) Drugs Market Share by Type: 2020 VS 2027
Figure 2. Codeine Features
Figure 3. Fentanyl Features
Figure 4. Hydrocodone Features
Figure 5. Hydromorphone Features
Figure 6. Meperidine Features
Figure 7. Methadone Features
Figure 8. Others Features
Figure 9. Global Narcotic (Opioid) Drugs Market Share by Application: 2020 VS 2027
Figure 10. Pain Relief Application Case Studies
Figure 11. Anesthesia Application Case Studies
Figure 12. Narcotic (Opioid) Drugs Report Years Considered
Figure 13. Global Narcotic (Opioid) Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Narcotic (Opioid) Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Narcotic (Opioid) Drugs Market Share by Regions: 2020 VS 2027
Figure 16. Global Narcotic (Opioid) Drugs Market Share by Regions (2022-2027)
Figure 17. Global Narcotic (Opioid) Drugs Market Share by Players in 2020
Figure 18. Global Top Narcotic (Opioid) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcotic (Opioid) Drugs as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Narcotic (Opioid) Drugs Revenue in 2020
Figure 20. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2016-2021)
Figure 21. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2022-2027)
Figure 22. North America Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Narcotic (Opioid) Drugs Market Share by Type (2016-2027)
Figure 24. North America Narcotic (Opioid) Drugs Market Share by Application (2016-2027)
Figure 25. North America Narcotic (Opioid) Drugs Market Share by Country (2016-2027)
Figure 26. United States Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Narcotic (Opioid) Drugs Market Share by Type (2016-2027)
Figure 30. Europe Narcotic (Opioid) Drugs Market Share by Application (2016-2027)
Figure 31. Europe Narcotic (Opioid) Drugs Market Share by Country (2016-2027)
Figure 32. Germany Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Narcotic (Opioid) Drugs Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Narcotic (Opioid) Drugs Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Narcotic (Opioid) Drugs Market Share by Region (2016-2027)
Figure 42. China Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Narcotic (Opioid) Drugs Market Share by Type (2016-2027)
Figure 50. Latin America Narcotic (Opioid) Drugs Market Share by Application (2016-2027)
Figure 51. Latin America Narcotic (Opioid) Drugs Market Share by Country (2016-2027)
Figure 52. Mexico Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Narcotic (Opioid) Drugs Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Narcotic (Opioid) Drugs Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Narcotic (Opioid) Drugs Market Share by Country (2016-2027)
Figure 58. Turkey Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Narcotic (Opioid) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Pfizer Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
Figure 62. Teva Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
Figure 63. Purdue Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
Figure 64. Mallinckrodt Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
Figure 65. Amneal Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
Figure 66. Collegium Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
Figure 68. Merck Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
Figure 69. Mylan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
Figure 70. Hikma Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
Figure 71. Sun Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
Figure 72. Endo Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
Figure 73. Allergan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

---